Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06717334 · ClinicalTrials.gov registry record
A Study of Lung Cancer Screening in People With Unexplained Weight Loss
A clinical trial of Lung Cancer Screening, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 409
- Enrollment target
- 8
- Study locations
NCT06717334: Recruiting study of Lung Cancer Screening, sponsored by Memorial Sloan Kettering Cancer Center.
NCT06717334 is a study of Lung Cancer Screening that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 409 participants, below the 471-participant average among 7 other Lung Cancer Screening trials with a reported enrollment target (13% lower). The trial reports 8 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06717334, a study of Lung Cancer Screening, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 409 participants
- Enrollment target
- 8
- Study locations
Study Summary
The researchers are doing this study to see if people with unexplained weight loss who have lung cancer screening are more likely to have or develop lung cancer than people without unexplained weight loss. The lung cancer screening will involve use of low-dose computed tomography (LDCT), a CT scan that gives off very low doses of radiation and can make detailed pictures of the lungs to help find tumors. The study researchers will also analyze participants' blood samples to determine if blood testing can be used to help to diagnose lung cancer.
Primary Outcome
Low Dose CT screening
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Low Dose CT imaging
- OTHER blood draws
- OTHER screening questionnaire
Study Locations (8)
New York
- Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities) - Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities) - Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
- Montefiore Health Systems (Montefiore Medical Center) - The Bronx
- Memorial Sloan Kettering Nassau (All Protocol Activities) - Uniondale
New Jersey
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities) - Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities) - Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 409 participants |
| Start Date | 2024-12-02 |
| Est. Completion | 2026-12 |
What NCT06717334 shows while recruiting
NCT06717334 is an observational study that tracks outcomes without assigning an intervention. The registered 409 participants enrollment target is mid-sized for trials with a published cap, below the 471-participant average among 7 other Lung Cancer Screening trials with a reported enrollment target (13% lower).
The record links to 1 condition, with Lung Cancer Screening appearing as the primary indexed condition, and to 3 interventions - of which Low Dose CT imaging is the first listed.
NCT06717334 lists 8 locations in 2 states (New York, New Jersey).
Frequently Asked Questions
What is clinical trial NCT06717334 about?
NCT06717334 is a clinical study titled "A Study of Lung Cancer Screening in People With Unexplained Weight Loss". The researchers are doing this study to see if people with unexplained weight loss who have lung cancer screening are more likely to have or develop lung cancer than people without unexplained weight loss. The lung cancer screening will involve use of low-dose computed tomography (LDCT), a CT scan t...
What is the current status of trial NCT06717334?
This trial is currently recruiting. The enrollment target is 409 participants. The study started on 2024-12-02. Estimated completion is 2026-12.
What conditions does trial NCT06717334 study?
This clinical trial studies the following conditions: Lung Cancer Screening.
What interventions are being tested in trial NCT06717334?
The interventions under investigation include: Low Dose CT imaging (DIAGNOSTIC_TEST), blood draws (OTHER), screening questionnaire (OTHER).
Who is sponsoring clinical trial NCT06717334?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06717334 being conducted?
This trial has 8 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Advancing Lung Cancer Screening One Text at a Time
RECRUITING · NA
-
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer
RECRUITING
-
CPRIT: Patient Adherence to Lung Cancer Screening
RECRUITING
-
Digitally Enhanced Smoking Cessation for High Risk Smokers
ACTIVE NOT RECRUITING · NA
-
Multilevel Interventions to Increase Adherence to Lung Cancer Screening
ACTIVE NOT RECRUITING · NA
-
The SHARED, Project, Lung Cancer Screening for African American Men (AAM)
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02043691 · 410 participants · NA
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
- NCT03042975 · 410 participants
Imaging Genetics of Laryngeal Dystonia
- NCT05730036 · 410 participants · Phase 3
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
- NCT05751473 · 410 participants · NA
Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in First Responders and Frontline Health Care Workers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI